Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 2

3(50.0%)

N/A

1(16.7%)

Phase 3

1(16.7%)

Phase 1

1(16.7%)

6Total

Phase 2(3)

N/A(1)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06696820Phase 2Completed

Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke

Role: collaborator

NCT06265051Phase 2Completed

Tirofiban After Successful MT Recanalization in AIS

Role: collaborator

NCT07361783Not ApplicableRecruiting

Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI 2 Trial

Role: collaborator

NCT07240467Phase 2Not Yet Recruiting

Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness

Role: collaborator

NCT01274793Phase 1Unknown

Trial for Quantity-Effect Relationship of Acupuncture With Two-ways Regulation to Treat Functional Enteropathy

Role: collaborator

NCT00689897Phase 3Unknown

Psychological Outcomes From a Study of Acupuncture Treatment on Experimentally Primary Dysmenorrhea

Role: collaborator

All 6 trials loaded